← FDA DRUG APPROVALS

FDA ANDA · ANDA207238

DICLOFENAC SODIUM

Sponsor: ACTAVIS LABS UT INC

APPLICATION
ANDA207238
TYPE
ANDA
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
None (Tentative Approval)

Products

DICLOFENAC SODIUMNone (Tentative Approval)
DICLOFENAC SODIUM 2% · SOLUTION · TOPICAL

Approval history

2017-11-02UNKNOWN · Original · standardLabelTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →